Fig. 2: Rates of achieving target tumor size, actual breast-conserving surgery (BCS) rate, and surgical plan for BCS at the end of treatment, stratified by 70-gene assay risk groups. | npj Breast Cancer

Fig. 2: Rates of achieving target tumor size, actual breast-conserving surgery (BCS) rate, and surgical plan for BCS at the end of treatment, stratified by 70-gene assay risk groups.

From: Personalized neoadjuvant strategy using 70-gene assay to increase breast-conserving surgery in ER+/HER2– breast cancer

Fig. 2

Bar graphs show (1) the rate of achieving the target tumor size for BCS based on imaging, (2) the actual BCS rate, and (3) the proportion of patients with a BCS surgical plan at the end of treatment. Results are shown for the total cohort (gray), genomic high-risk group (black), and genomic low-risk group (white). Error bars represent 95% confidence intervals.

Back to article page